UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Idebenone improves respiratory function in pediatric and adolescent patients with Duchenne muscular dystrophy not using glucocorticoid steroids

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S262-S262

Buyse, G

2015

Volltextzugriff (PDF)

Efficacy of idebenone in respiratory decline in Duchenne muscular dystrophy (DMD): comparison of analysis methods

Neuromuscular disorders : NMD, 2018, Vol.28, p.S17

2018

Volltextzugriff (PDF)

074 Long-term effect of idebenone in reducing respiratory function decline in patients with Duchenne muscular dystrophy

Journal of neurology, neurosurgery and psychiatry, 2022-06, Vol.93 (6), p.A35-A35

2022

Volltextzugriff (PDF)

Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance

European heart journal, 2009-01, Vol.30 (1), p.116-124

2009

Volltextzugriff (PDF)

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

The Lancet (British edition), 2015-05, Vol.385 (9979), p.1748-1757

2015

Volltextzugriff (PDF)

Idebenone Reduces Loss of Respiratory Function in Duchenne Muscular Dystrophy: Outcome of a Phase III Double Blind, Randomized, Placebo-Controlled Trial

Neuropediatrics, 2015, Vol.46 (S 01)

2015

Volltextzugriff (PDF)

Effect of idebenone on bronchopulmonary adverse events and hospitalizations in patients with Duchene muscular dystrophy (DMD)

Neuromuscular disorders : NMD, 2018, Vol.28, p.S16-S17

2018

Volltextzugriff (PDF)

Metabolism of stevioside in pigs and intestinal absorption characteristics of stevioside, rebaudioside A and steviol

Food and chemical toxicology, 2003-11, Vol.41 (11), p.1599-1607

2003

Volltextzugriff (PDF)

Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring

Neurology, 2003-05, Vol.60 (10), p.1679-1681

2003

Volltextzugriff (PDF)

Correlation of respiratory function parameters in 10–18 year old patients with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S200-S201

2015

Volltextzugriff (PDF)

A phase III double-blind, randomized, placebo-controlled study (SIDEROS) assessing the efficacy of idebenone in slowing the rate of respiratory function loss in patients with Duchenne muscular dystrophy receiving glucocorticoid steroids

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S157-S157

2016

Volltextzugriff (PDF)

Refinement of cortical dysgeneses spectrum associated with TUBA1A mutations

Journal of medical genetics, 2008-10, Vol.45 (10), p.647-653

2008

Volltextzugriff (PDF)

Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial

Seizure (London, England), 2005, Vol.14 (1), p.66-71

2005

Volltextzugriff (PDF)

G.P.252 - Idebenone improves respiratory function in pediatric and adolescent patients with Duchenne muscular dystrophy not using glucocorticoid steroids

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S262-S262

Buyse, G.

2015

Volltextzugriff (PDF)

T.P.6

Neuromuscular disorders : NMD, 2014-10, Vol.24 (9), p.862-862

2014

Volltextzugriff (PDF)

Reference values for the three-minute walk test, North Star ambulatory assessment and timed tests in typically developing boys aged 2.5–5 years

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S228-S228

2015

Volltextzugriff (PDF)

Assessment of early motor development in young boys with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S228-S229

2015

Volltextzugriff (PDF)

PRRT2 mutations: exploring the phenotypical boundaries

Journal of neurology, neurosurgery and psychiatry, 2014-04, Vol.85 (4), p.462-465

2014

Volltextzugriff (PDF)

Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S156-S156

2016

Volltextzugriff (PDF)

Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S156-S157

2016

Volltextzugriff (PDF)

MRI findings in acute cerebellitis

European radiology, 2004-08, Vol.14 (8), p.1478-1483

2004

Volltextzugriff (PDF)

PP09.6 – 2400: Reference values for the three-minute walk test, North Star Ambulatory Assessment and timed tests in typically developing boys aged 2.5–5 years

European journal of paediatric neurology, 2015-05, Vol.19, p.S66-S66

2015

Volltextzugriff (PDF)

The use of a hand-held device (ASMA-1) for home-based monitoring of respiratory function changes in pediatric and adolescent patients with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S201-S201

2015

Volltextzugriff (PDF)

Natural history of respiratory function changes in patients with Duchenne muscular dystrophy not using glucocorticoid steroids

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S305-S305

2015

Volltextzugriff (PDF)

DELOS Phase III Study with Idebenone (Catena®) in Duchenne Muscular Dystrophy

Neuropediatrics, 2012, Vol.43 (2)

2012

Volltextzugriff (PDF)

1 – 25 von 482

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(438)
Mit Volltextzugriff
(390)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(247)
Life Sciences & Biomedicine
(239)
Humans
(189)
Female
(137)
Male
(128)
Biological And Medical Sciences
(106)
Medical Sciences
(97)
Animals
(86)
Middle Aged
(70)
Adult
(63)
Oncology
(48)
Aged
(45)
Agriculture
(43)
Neurology
(43)
Agriculture, Dairy & Animal Science
(41)
Pharmacology. Drug Treatments
(39)
Treatment Outcome
(38)
Adolescent
(33)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Chemotherapy
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Idebenone improves respiratory function in pediatric and adolescent patients with Duchenne muscular dystrophy not using glucocorticoid steroids

Efficacy of idebenone in respiratory decline in Duchenne muscular dystrophy (DMD): comparison of analysis methods

074 Long-term effect of idebenone in reducing respiratory function decline in patients with Duchenne muscular dystrophy

Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

Idebenone Reduces Loss of Respiratory Function in Duchenne Muscular Dystrophy: Outcome of a Phase III Double Blind, Randomized, Placebo-Controlled Trial

Effect of idebenone on bronchopulmonary adverse events and hospitalizations in patients with Duchene muscular dystrophy (DMD)

Metabolism of stevioside in pigs and intestinal absorption characteristics of stevioside, rebaudioside A and steviol

Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring

Correlation of respiratory function parameters in 10–18 year old patients with Duchenne muscular dystrophy

A phase III double-blind, randomized, placebo-controlled study (SIDEROS) assessing the efficacy of idebenone in slowing the rate of respiratory function loss in patients with Duchenne muscular dystrophy receiving glucocorticoid steroids

Refinement of cortical dysgeneses spectrum associated with TUBA1A mutations

Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial

G.P.252 - Idebenone improves respiratory function in pediatric and adolescent patients with Duchenne muscular dystrophy not using glucocorticoid steroids

T.P.6

Reference values for the three-minute walk test, North Star ambulatory assessment and timed tests in typically developing boys aged 2.5–5 years

Assessment of early motor development in young boys with Duchenne muscular dystrophy

PRRT2 mutations: exploring the phenotypical boundaries

Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy

Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy

MRI findings in acute cerebellitis

PP09.6 – 2400: Reference values for the three-minute walk test, North Star Ambulatory Assessment and timed tests in typically developing boys aged 2.5–5 years

The use of a hand-held device (ASMA-1) for home-based monitoring of respiratory function changes in pediatric and adolescent patients with Duchenne muscular dystrophy

Natural history of respiratory function changes in patients with Duchenne muscular dystrophy not using glucocorticoid steroids

DELOS Phase III Study with Idebenone (Catena®) in Duchenne Muscular Dystrophy

Suchergebnisse filtern